Figure 1.
Comparison of miR-125b expression in the control, primary and metastasis groups. Data were compared by one-way ANOVA and a least significant difference post hoc test. **P<0.01 and ***P<0.001. Control, intradermal nevus control group; metastasis, metastatic melanoma group; miR-125b, microRNA-125b; primary, primary melanoma group.